NCT06111235Phase 3Active not recruiting

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Study sponsor: CG Oncology, Inc. · CGON

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-11Estimated
Enrollment · participants367Actual
Source updated2026-07-01Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jun 2026. After: Nov 2026.

Check registry source

· 1 field changed

Primary completion date changed

Before: Jan 2028. After: Jun 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview